Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis

Arshad, 2011, NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis, Eur. J. Immunol., 41, 2341, 10.1002/eji.201041332 Barlow, 2012, Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity, J. Allergy Clin. Immunol., 129, 191, 10.1016/j.jaci.2011.09.041 Bartemes, 2011, IL-33-Responsive Lineage-CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs, J. Immunol., 188, 1503, 10.4049/jimmunol.1102832 Bataller, 2005, Liver fibrosis, J. Clin. Invest., 115, 209, 10.1172/JCI24282 Benyon, 1996, Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver, Gastroenterology, 110, 821, 10.1053/gast.1996.v110.pm8608892 Besnard, 2011, IL-33-activated dendritic cells are critical for allergic airway inflammation, Eur. J. Immunol., 41, 1675, 10.1002/eji.201041033 Blank, 2010, Long-term genetic stability and population dynamics of laboratory strains of Schistosoma mansoni, J. Parasitol., 96, 900, 10.1645/GE-2463.1 Cayrol, 2009, The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1, Proc. Natl. Acad. Sci. USA, 106, 9021, 10.1073/pnas.0812690106 Chackerian, 2007, IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex, J. Immunol., 179, 2551, 10.4049/jimmunol.179.4.2551 Chang, 2011, Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity, Nat. Immunol., 12, 631, 10.1038/ni.2045 Elsharkawy, 2010, The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes, J. Hepatol., 53, 519, 10.1016/j.jhep.2010.03.025 Friedman, 2008, Mechanisms of hepatic fibrogenesis, Gastroenterology, 134, 1655, 10.1053/j.gastro.2008.03.003 Friedman, 2010, Evolving challenges in hepatic fibrosis, Nat Rev Gastroenterol Hepatol, 7, 425, 10.1038/nrgastro.2010.97 Haraldsen, 2009, Interleukin-33 - cytokine of dual function or novel alarmin?, Trends Immunol., 30, 227, 10.1016/j.it.2009.03.003 Hebenstreit, 2006, Signaling mechanisms, interaction partners, and target genes of STAT6, Cytokine Growth Factor Rev., 17, 173, 10.1016/j.cytogfr.2006.01.004 Hoyler, 2012, The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells, Immunity, 37, 634, 10.1016/j.immuni.2012.06.020 Jin, 2011, Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells, Hepatology, 53, 219, 10.1002/hep.23983 Kang, 2012, Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(-)c-Kit(+) innate cell population, Immunity, 36, 821, 10.1016/j.immuni.2012.03.021 Koyasu, 2011, Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population, Curr. Opin. Allergy Clin. Immunol., 11, 109, 10.1097/ACI.0b013e3283448808 Kroeger, 2009, IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway, J. Leukoc. Biol., 86, 769, 10.1189/jlb.0708452 Liew, 2010, Disease-associated functions of IL-33: the new kid in the IL-1 family, Nat. Rev. Immunol., 10, 103, 10.1038/nri2692 Liu, 1999, Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA, Gene Ther., 6, 1258, 10.1038/sj.gt.3300947 Liu, 2011, IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent Smad signaling, J. Immunol., 187, 2814, 10.4049/jimmunol.1003260 Louten, 2011, Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation, Int. Immunol., 23, 307, 10.1093/intimm/dxr006 Lüthi, 2009, Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases, Immunity, 31, 84, 10.1016/j.immuni.2009.05.007 Marvie, 2010, Interleukin-33 overexpression is associated with liver fibrosis in mice and humans, J. Cell. Mol. Med., 14, 1726, 10.1111/j.1582-4934.2009.00801.x Mjösberg, 2011, Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161, Nat. Immunol., 12, 1055, 10.1038/ni.2104 Mohrs, 2001, Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter, Immunity, 15, 303, 10.1016/S1074-7613(01)00186-8 Monticelli, 2011, Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus, Nat. Immunol., 12, 1045, 10.1038/ni.2131 Moro, 2010, Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells, Nature, 463, 540, 10.1038/nature08636 Neill, 2010, Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity, Nature, 464, 1367, 10.1038/nature08900 Oboki, 2010, IL-33 is a crucial amplifier of innate rather than acquired immunity, Proc. Natl. Acad. Sci. USA, 107, 18581, 10.1073/pnas.1003059107 Ohnmacht, 2010, Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths, Immunity, 33, 364, 10.1016/j.immuni.2010.08.011 Palmer, 2011, Interleukin-33 biology with potential insights into human diseases, Nat Rev Rheumatol, 7, 321, 10.1038/nrrheum.2011.53 Palmer, 2008, The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33, Cytokine, 42, 358, 10.1016/j.cyto.2008.03.008 Price, 2010, Systemically dispersed innate IL-13-expressing cells in type 2 immunity, Proc. Natl. Acad. Sci. USA, 107, 11489, 10.1073/pnas.1003988107 Rankin, 2010, IL-33 induces IL-13-dependent cutaneous fibrosis, J. Immunol., 184, 1526, 10.4049/jimmunol.0903306 Saenz, 2010, Innate immune cell populations function as initiators and effectors in Th2 cytokine responses, Trends Immunol., 31, 407, 10.1016/j.it.2010.09.001 Saenz, 2010, IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses, Nature, 464, 1362, 10.1038/nature08901 Schmitz, 2005, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, Immunity, 23, 479, 10.1016/j.immuni.2005.09.015 Seki, 2009, CCR1 and CCR5 promote hepatic fibrosis in mice, J. Clin. Invest., 119, 1858 Stolarski, 2010, IL-33 exacerbates eosinophil-mediated airway inflammation, J. Immunol., 185, 3472, 10.4049/jimmunol.1000730 van Rooijen, 2003, “In vivo” depletion of macrophages by liposome-mediated “suicide”, Methods Enzymol., 373, 3, 10.1016/S0076-6879(03)73001-8 Volarevic, 2012, Protective role of IL-33/ST2 axis in Con A-induced hepatitis, J. Hepatol., 56, 26, 10.1016/j.jhep.2011.03.022 Wasmuth, 2010, Chemokines in liver inflammation and fibrosis, Semin. Liver Dis., 30, 215, 10.1055/s-0030-1255351 Weiler-Normann, 2007, Mouse models of liver fibrosis, Z. Gastroenterol., 45, 43, 10.1055/s-2006-927387 Wilhelm, 2011, An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation, Nat. Immunol., 12, 1071, 10.1038/ni.2133 Wills-Karp, 2008, Untangling the Complex Web of IL-4-and IL-13-Mediated Signaling Pathways, Sci. Signal., 25, 1 Wong, 2012, Transcription factor RORα is critical for nuocyte development, Nat. Immunol., 13, 229, 10.1038/ni.2208 Xu, 2008, IL-33 exacerbates antigen-induced arthritis by activating mast cells, Proc. Natl. Acad. Sci. USA, 105, 10913, 10.1073/pnas.0801898105 Yanaba, 2011, Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis, Clin. Rheumatol., 30, 825, 10.1007/s10067-011-1686-5